Search Results - "Bruin, Peter C."

Refine Results
  1. 1

    Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial by Exterkate, Leonie, Wegelin, Olivier, Barentsz, Jelle O., Leest, Marloes G., Kummer, J. Alain, Vreuls, Willem, Bruin, Peter C., Witjes, J. Alfred, Melick, Harm H.E., Somford, Diederik M.

    Published in BJU international (01-03-2023)
    “…Objectives To assess the proportion of clinically significant (cs) prostate cancer (PCa) found during follow‐up in patients with negative systematic biopsy…”
    Get full text
    Journal Article
  2. 2

    Histopathologic composition of cerebral thrombi of acute stroke patients is correlated with stroke subtype and thrombus attenuation by Niesten, Joris M, van der Schaaf, Irene C, van Dam, Lievay, Vink, Aryan, Vos, Jan Albert, Schonewille, Wouter J, de Bruin, Peter C, Mali, Willem P T M, Velthuis, Birgitta K

    Published in PloS one (11-02-2014)
    “…We related composition of cerebral thrombi to stroke subtype and attenuation on non-contrast CT (NCCT) to gain more insight in etiopathogenesis and to validate…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Molecular subtyping of male breast cancer by immunohistochemistry by Kornegoor, Robert, Verschuur-Maes, Anoek H J, Buerger, Horst, Hogenes, Marieke C H, de Bruin, Peter C, Oudejans, Joost J, van der Groep, Petra, Hinrichs, Bernd, van Diest, Paul J

    Published in Modern pathology (01-03-2012)
    “…Molecular subtyping of breast cancer by gene expression has proven its significance in females. Immunohistochemical surrogates have been used for this…”
    Get full text
    Journal Article
  5. 5

    Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification by Kornegoor, Robert, Moelans, Cathy B., Verschuur-Maes, Anoek H. J., Hogenes, Marieke C. H., de Bruin, Peter C., Oudejans, Joost J., Marchionni, Luigi, van Diest, Paul J.

    Published in Breast cancer research and treatment (01-08-2012)
    “…Gene amplification is an important mechanism for oncogene activation, a crucial step in carcinogenesis. Compared to female breast cancer, little is known on…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Do columnar cell lesions exist in the male breast? by Verschuur-Maes, Anoek H J, Kornegoor, Robert, de Bruin, Peter C, Oudejans, Joost J, van Diest, Paul J

    Published in Histopathology (01-05-2014)
    “…Aims In females, columnar cell lesions (CCLs) have been recognized as putative precursor lesions of low‐grade breast cancer, but their role in male breast…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The estimation of tumor cell percentage for molecular testing by pathologists is not accurate by Smits, Alexander J J, Kummer, J Alain, de Bruin, Peter C, Bol, Mijke, van den Tweel, Jan G, Seldenrijk, Kees A, Willems, Stefan M, Offerhaus, G Johan A, de Weger, Roel A, van Diest, Paul J, Vink, Aryan

    Published in Modern pathology (01-02-2014)
    “…Molecular pathology is becoming more and more important in present day pathology. A major challenge for any molecular test is its ability to reliably detect…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The additional value of EUS-guided Tru-cut biopsy to EUS-guided FNA in patients with mediastinal lesions by Berger, Lieke P.V., MD, Scheffer, Robert C.H., MD, PhD, Weusten, Bas L.A.M., MD, PhD, Seldenrijk, Cees A., MD, PhD, de Bruin, Peter C., MD, PhD, Timmer, Robin, MD, PhD, Stolk, Mark F.J., MD, PhD

    Published in Gastrointestinal endoscopy (01-05-2009)
    “…Background and Objective EUS-guided FNA is a sensitive method to obtain cytologic specimens from solid lesions in close proximity to the GI tract. Although FNA…”
    Get full text
    Journal Article
  12. 12

    Histopathologic Studies of the Below‐the‐Knee Great Saphenous Vein after Endovenous Laser Ablation by Der KINDEREN, DAAN J., DISSELHOFF, BEN C. V. M., KOTEN, JAN WILLEM, De BRUIN, PETER. C., SELDENRIJK, CEES A., MOLL, FRANS L.

    Published in Dermatologic surgery (01-12-2009)
    “…BACKGROUND There has been hesitation to use endovenous laser ablation (EVLA) for the treatment of incompetence of the below‐the‐knee great saphenous vein…”
    Get full text
    Journal Article
  13. 13

    Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression by Amaador, Karima, Vos, Josephine M. I., Pals, Steven T., Kraan, Willem, Dobber, Johan A., Minnema, Monique C., Koene, Harry R., de Bruin, Peter C., Zwinderman, Aiko H., Kersten, Marie José

    Published in Leukemia & lymphoma (16-04-2022)
    “…Discrimination between Waldenström macroglobulinemia (WM) and marginal zone lymphoma (MZL) of the bone marrow (BM) can be difficult due to overlap in clinical,…”
    Get full text
    Journal Article
  14. 14

    Isolated tumor cells in breast cancer sentinel lymph nodes: displacement or metastases? An immunohistochemical study by van Deurzen, Carolien H.M., MD, de Bruin, Peter C., MD, PhD, Koelemij, Ron, MD, PhD, Hillegersberg, Richard, MD, PhD, van Diest, Paul J., MD, PhD

    Published in Human pathology (01-06-2009)
    “…Summary The tumorigenic origin and progression capacity of isolated tumor cells in breast cancer sentinel lymph nodes are uncertain. True lymph node metastases…”
    Get full text
    Journal Article
  15. 15

    Invasive inflammatory myofibroblastic tumor of the lung by van den Heuvel, Daniel A, Keijsers, Ruth G, van Es, Hendrik W, Bootsma, Gerben P, de Bruin, Peter C, Schramel, Franz M, van Heesewijk, Johannes P

    Published in Journal of thoracic oncology (01-07-2009)
    “…Inflammatory myofibroblastic tumor (IMT) of the lung is a rare tumor but it should be considered when dealing with primary lung tumors in children,…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification by Kornegoor, Robert, Moelans, Cathy B, Verschuur-Maes, Anoek Hj, Hogenes, Marieke Ch, de Bruin, Peter C, Oudejans, Joost J, van Diest, Paul J

    Published in Breast cancer research : BCR (05-07-2012)
    “…Epigenetic events are, along with genetic alteration, important in the development and progression of cancer. Promoter hypermethylation causes gene silencing…”
    Get full text
    Journal Article
  18. 18

    Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer by Verschuur-Maes, Anoek H. J., de Bruin, Peter C., van Diest, Paul J.

    Published in Breast cancer research and treatment (01-12-2012)
    “…Promoter hypermethylation of several tumour suppressor genes often occurs during breast carcinogenesis, but little is known about epigenetic silencing in the…”
    Get full text
    Journal Article
  19. 19

    Immunophenotyping of male breast cancer by Kornegoor, Robert, Verschuur-Maes, Anoek H J, Buerger, Horst, Hogenes, Marieke C, de Bruin, Peter C, Oudejans, Joost J, Hinrichs, Bernd, van Diest, Paul J

    Published in Histopathology (01-12-2012)
    “…Kornegoor R, Verschuur‐Maes A H J, Buerger H, Hogenes M C, de Bruin P C, Oudejans J J, Hinrichs B & van Diest P J 
(2012) Histopathology
Immunophenotyping of…”
    Get full text
    Journal Article
  20. 20

    Fibrotic focus and hypoxia in male breast cancer by Kornegoor, Robert, Verschuur-Maes, Anoek H J, Buerger, Horst, Hogenes, Marieke C H, de Bruin, Peter C, Oudejans, Joost J, Hinrichs, Bernd, van Diest, Paul J

    Published in Modern pathology (01-10-2012)
    “…Fibrotic focus is a scar-like lesion near the center of a carcinoma and has been associated with high-grade, lymph node metastases and poor survival in female…”
    Get full text
    Journal Article